Chronic Wound Care Market Share

  • Report ID: 4450
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Chronic Wound Care Market Regional Analysis:

APAC Market Insights        

The Asia Pacific region is anticipated to witness the fastest growth in the upcoming years, backed by the rising number of diabetic patients along with the rapidly increasing elderly population. Moreover, there has been a surge in healthcare expenditure that is further expected to boost the market’s growth in the region.

North American Market  Insights

North America region is projected to account for more than 38.1% market share by 2035, attributed to a large chronic wound patient pool, high prevalence of diabetic foot ulcers, and supportive reimbursement policies. For instance, in 2019, approximately 8 to 13 million people were affected by chronic wounds in the United States.  Moreover, there has been a surge in the number of sports related injuries in countries such as the U.S., that is expected to drive the market’s growth in the region.

Chronic Wound Care Market Share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of chronic wound care is assessed at USD 16.47 billion.

The global chronic wound care market size was valued at around USD 15.73 billion in 2025 and is projected to grow at a CAGR of more than 5.2%, reaching USD 26.11 billion revenue by 2035.

The North America chronic wound care market will hold over 38.1% share by 2035, attributed to a large chronic wound patient pool, high prevalence of diabetic foot ulcers, and supportive reimbursement policies.

Key players in the market include Smith & Nephew PLC, Ölnlycke Health Care AB, ConvaTec, Inc., Integra LifeSciences Corporation, Coloplast A/S, Cardinal Health, Inc., Tissue Regenix Ltd, B. Braun Melsungen AG, MIMEDX, Inc., 3M.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos